← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Ginkgo Bioworks, Inc.
Boston, MA
$25,168,412
Total funding
6
Grants
Funding over time
peak $13.1M · FY2010–24$20M$15M$10M$5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
DOE$14,496,937 · 2
DOD$9,871,484 · 2
USDA$649,992 · 1
NIH$150,000 · 1
By mechanism
—$25,018,412 · 5
R43$150,000 · 1
Investigators at Ginkgo Bioworks, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
TAS::89 0336::TAS RECOVERY GINKGO BIOWORKS (BOSTON, MA). THIS PROJECT SEEKS TO DEVELOP AN "ELECTROFUELS CHASSIS" BY USING ENGINEERED E. COLI TO CONVE$13,106,793
· FY2010 · Department of Energy
DISCOVERY AND DEVELOPMENT OF ENZYMES FOR WASTE/MATERIAL DEGRADATION$6,672,562
· FY2019 · Department of the Army
COOPERATIVE AGREEMENT$3,198,922
· FY2024 · Department of the Army
INTEGRATED PEST MANAGEMENT-INSPIRED APPROACH TO ALGAL CROP PROTECTION BASED ON LABORATORY EVOLUTION AND ENGINEERED ANTIMICROBIAL PEPTIDES$1,390,144
· FY2023 · Department of Energy
** AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF THE CURRENT ADMINISTRATION.** SINCE LATE 2019, SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) HAS INFECTED MILLIONS OF PEOPLE. AROUND 60% OF DISEASES THAT CAN INFECT HUMANS ALSO INFECT ANIMALS,AND MILLIONS OF WHITE-TAILED DEER ('DEER') LIVE IN THE UNITED STATES, INCLUDING ON THOUSANDS OF FARMS WHERE THEY INTERACT CLOSELY WITH PEOPLE AND SUPPORT JOBS, PROVIDE FOOD, AND ENHANCE RECREATION. EARLY IN THE PANDEMIC, USDA SCIENTISTS TESTED WILD DEER FOR SARS-COV-2 AND FOUND THAT ON AVERAGE ONE IN THREE WERE POSITIVE FOR SARS-COV-2. TO LEARN MORE ABOUT WHAT VARIANTS LIKE ALPHA, DELTA, AND OMICRON THE DEER WERE INFECTED BY, SCIENTISTS USED GENE SEQUENCING TO READ THE GENETIC CODE OF THE VIRUS. SEQUENCING THE VIRUS FROM WILD DEER UNCOVERED SARS-COV-2 VERSIONS NOT FOUND IN PEOPLE, AND THESE SAME UNIQUE SEQUENCES INDICATED THAT AT LEAST ONE PERSON WAS INFECTED BY SARS-COV-2 FROM A DEER. THESE SURPRISING DISCOVERIES RAISED EVEN MORE QUESTIONS ABOUT SARS-COV-2 IN DEER SINCE THEY SUGGESTED THAT DEER ARE EASILY INFECTED WITH SARS-COV-2 AND MAY ALSO TRANSMIT THE VIRUS TO EACH OTHER. WE NEED MORE RESEARCH TO UNDERSTAND HOW SARS-COV-2 IS SPREADING IN DEER, AND WE ALSO NEED TO MEASURE THE RISK THAT THIS VIRUS WILL MUTATE IN DEER AND CREATE NEW VIRUS VARIANTS THAT CAN HARM DEER, PEOPLE OR OTHER ANIMALS. SO FAR ONLY A TINY FRACTION OF DEER IN THE US, WILD OR FARMED, HAVE BEEN TESTED FOR SARS-COV-2, AND EVEN FEWER HAVE HAD THEIR VIRUS INFECTION SEQUENCED. TO HELP US UNDERSTAND HOW THE SARS-COV-2 VIRUS IMPACTS FARMED DEER, AND HELP US SOLVE PROBLEMS THE VIRUS MIGHT CAUSE FARMERS OR THE PUBLIC, THE EXTENSIVE DEER GENOMIC SURVEILLANCE (EDGES) PROJECT WILL TEST AND SEQUENCE SARS-COV-2 IN THOUSANDS OF FARMED AND WILD DEER, AND ANIMALS THE DEER INTERACT WITH, FROM TEXAS. THE GOAL OF THIS EFFORT IS TO UNDERSTAND IF, WHEN, AND HOW BOTH FARMED AND WILD DEER ARE BECOMING INFECTED WITH SARS-COV-2 TO HELP FARMERS LIMIT THE SPREAD OF SARS-COV-2 TO OTHER DEER, ANIMALS, OR PEOPLE. WE EXPECT THAT THE RESULTS OFVIRUS TESTING WILL SHOW THAT MANY FARMED DEER ARE INFECTED WITH SARS-COV-2 VIRUS, AND THE EXPECTED SEQUENCING RESULTS WILL PROVIDE EVIDENCE ABOUT THE ORIGIN OF FARMED DEER INFECTIONS. ULTIMATELY, PROJECT EDGES WILL PROTECT BOTH FARMED DEER AND DEER FARMERS BY IMPROVING OUR ABILITY TO FIND, UNDERSTAND, AND STOP THE SARS-COV-2 VIRUS IN AGRICULTURAL ANIMALS THAT PEOPLE DEPEND ON FOR JOBS, FOOD, AND SPORT.$649,992
· FY2023 · National Institute of Food and Agriculture
Microbial Platform for Accessing Plant Alkaloids$150,000
R43 · FY2013 · TR